Investing in an Irish-Domiciled, LSE-Listed S&P 500 ETF (CSPX) from India: The Complete Guide

Most Indian investors who want S&P 500 exposure think of the domestic fund route first: a Motilal Oswal or ICICI Prudential fund-of-funds that wraps an overseas ETF in a domestic mutual fund structure. Fewer know that there is a more direct, lower-cost alternative that is fully accessible under the Liberalised Remittance Scheme: buying an Irish-domiciled, London Stock Exchange-listed UCITS ETF that tracks the S&P 500 directly.

The most prominent example is the iShares Core S&P 500 UCITS ETF, traded on the LSE under the ticker CSPX in US dollars. It is managed by BlackRock Asset Management Ireland Limited, domiciled in Ireland, subject to EU UCITS regulation, with a total expense ratio of 0.07 percent per annum, and an AUM of approximately USD 148 billion as of June 2026, making it one of the largest ETFs in the world. For an Indian investor who opens an international brokerage account and remits funds under LRS, buying CSPX is as straightforward as buying any stock on the LSE.

This article explains why the Irish domicile matters, how CSPX compares to the domestic Indian fund route for S&P 500 exposure, what the annual returns of CSPX have been year-by-year since inception, how the S&P 500 has compared to the Nifty 50 and Nifty 500 in both rupee and dollar terms over multiple periods, and what the complete tax and compliance picture looks like for an Indian resident investing through the LRS route.

Why Ireland? Why the LSE? The Structural Reasons

Ireland is the preferred domicile for UCITS ETFs used by non-US investors for a specific tax reason: the US-Ireland tax treaty reduces withholding tax on dividends paid by US companies to an Irish-domiciled fund from 30 percent to 15 percent. A US-domiciled ETF like SPY or VOO, which most Indian investors have heard of, would be subject to a 30 percent withholding tax on dividends received from its US holdings because there is no equivalent treaty benefit for a US-domiciled fund holding US stocks.

This means an Irish-domiciled S&P 500 ETF like CSPX permanently loses 15 percent of the gross dividend yield of the S&P 500 to withholding tax, rather than the 30 percent a fund domiciled in a non-treaty jurisdiction would lose. The S&P 500's current dividend yield is approximately 1.3 percent.

A 15 percent withholding on this versus a 30 percent withholding produces a difference of roughly 0.20 percent per annum in retained earnings. Over 20 years at 15 percent compounded, this 0.20 percent additional drag compounds into a meaningful return difference. Ireland's treaty position makes it the most tax-efficient accessible domicile for non-US investors in US equity ETFs.

The London Stock Exchange listing makes CSPX accessible without a US brokerage account. Many international brokerages that Indian residents use (Interactive Brokers International, IBKR Singapore, and similar) provide access to the LSE alongside the major US exchanges. Trading in GBP or USD on the LSE does not require a separate regulatory relationship with US securities regulators, and the settlement infrastructure (Euroclear, Clearstream) is standard for European securities.

The UCITS (Undertakings for Collective Investment in Transferable Securities) classification means the fund is regulated under EU law, specifically the UCITS Directive, which sets standards for fund diversification, liquidity, and investor protection. The regulation is independent of SEBI, but UCITS is one of the most widely recognised and respected fund regulatory frameworks globally, used as the standard for internationally distributed funds across more than 70 countries.

Parameter	CSPX (iShares Core S&P 500 UCITS ETF)	Domestic Indian FoF (e.g. Motilal Oswal S&P 500)
ETF domicile	Ireland (UCITS)	India (SEBI-registered mutual fund investing in CSPX or equivalent)
Exchange listed on	London Stock Exchange (LSE); also Euronext and Xetra	Not exchange-listed; NAV-based open-ended mutual fund
Bloomberg ticker	CSPX LN (USD class); also available in GBP and EUR classes	Not applicable; transacted at daily NAV via AMC or platforms
ISIN	IE00B5BMR087	Individual fund-specific ISIN
Total Expense Ratio	0.07% per annum	Approximately 0.50 to 0.65% per annum (domestic wrapper cost) plus CSPX's 0.07% embedded
Dividend treatment	Accumulating (reinvests dividends; no cash distribution)	Effectively accumulating via NAV growth
US dividend withholding	15% (Ireland-US treaty); 1.3% dividend yield * 15% = 0.20% drag	Same underlying drag; both invest in same US stocks
AUM	USD 148 billion (June 2026)	Domestic wrapper AUM only; substantially smaller
Launch date	19 May 2010	Varies by Indian fund; most launched 2018 to 2021
How Indian investor accesses it	LRS-funded international brokerage; buy on LSE like any stock	Standard mutual fund SIP or lumpsum via any Indian platform or AMC

CSPX's Actual Performance Record: Year by Year

CSPX has a continuous return record from its launch in May 2010. The calendar year returns (in USD) from the iShares fact sheet, representing the accumulating share class, are as follows.

Calendar Year	CSPX Return (USD)	Context
2015	+0.99%	Flat year for US equities; strong US dollar; emerging markets declined sharply
2016	+11.54%	Trump election rally; financials and energy led; Nifty 50 fell in rupee terms post-demonetisation
2017	+21.40%	Strong global equity rally; low volatility; technology and growth stocks led
2018	-4.72%	Trade war; Fed rate hikes; fourth-quarter selloff; global equities broadly negative
2019	+31.02%	Strongest year since 2013; Fed pivot to dovish; broad US equity rally
2020	+18.02%	COVID crash in March; tech-led recovery; pandemic winners dominated returns
2021	+28.36%	Post-vaccine reopening; inflation concerns emerged late in year; growth still dominated
2022	-18.35%	Fastest Fed rate hiking cycle in 40 years; growth stocks collapsed; worst year since 2008
2023	+25.92%	AI narrative began; Nvidia and mega-cap tech drove index; strong recovery from 2022
2024	+24.69%	Continued AI-driven rally; S&P 500 hit multiple all-time highs; mega-cap dominance continued
2025 (partial, to Nov 2025)	+17.54% year-to-date as of Nov 2025 per factsheet	AI-semiconductor cycle continued; SpaceX IPO anticipation drove tech sentiment
3Y annualised (as of Nov 2025)	+20.24% per annum	Exceptional 3-year period driven by post-COVID recovery and AI cycle
5Y annualised (as of Nov 2025)	+14.96% per annum	Strong 5-year run; includes 2022 drawdown
Since inception annualised (May 2010 to Nov 2025)	+14.10% per annum	15-year compounding in USD from Irish-domiciled UCITS ETF

The one-year total return of CSPX as of June 2026 was 27.67 percent, reflecting the continued strong performance of US equities through the SpaceX IPO period and the ongoing AI infrastructure investment cycle.

CSPX has delivered 14.10% per annum in USD since its May 2010 inception. A USD 10,000 investment at inception would be worth approximately USD 71,000 by late 2025 — a 7.1x return in 15 years, at a total cost of 0.07% per annum in management fees.

The Critical Comparison: S&P 500 vs Nifty 50 and Nifty 500

This is the comparison that most Indian investors want and most Indian financial content gets wrong. The standard presentation shows the Nifty 50 or Nifty 500 in rupee terms against the S&P 500 in dollar terms and concludes that India has outperformed. A 25-year comparison showing Nifty up 1,400 percent versus S&P 500 up 321 percent is frequently cited.

This comparison is misleading because it ignores the fact that the rupee has depreciated substantially against the dollar over those 25 years. An Indian investor investing in the S&P 500 earns returns in dollars, which then convert to more rupees as the rupee falls. To make the comparison fair, both must be measured in the same currency.

The correct comparison requires one of two approaches: compare both indices in rupee terms (converting S&P 500 dollar returns to rupees using the actual USD/INR exchange rate for each year), or compare both in dollar terms (converting Nifty returns from rupees to dollars). Both produce the same conclusion if done correctly.

The USD/INR Currency Effect: The Silent Return Enhancer

The rupee has depreciated against the dollar at approximately 3 to 4 percent per annum over long periods. This depreciation means that every dollar earned on an S&P 500 investment translates to progressively more rupees when converted back. An Indian investor who bought CSPX in 2010 when the USD/INR rate was approximately 45 and sees a rate of approximately 84 in 2026 has received a 87 percent currency boost purely from rupee depreciation, before any S&P 500 returns are counted.

Concretely: if CSPX delivered 14.10 percent per annum in USD since inception (2010 to 2025), and the USD/INR rate moved from approximately 45 to approximately 84 over the same period (an annualised depreciation of approximately 4.1 percent per annum), the annualised rupee return for an Indian investor in CSPX would be approximately 18.2 percent per annum. This is the S&P 500 return plus the currency effect in rupee terms.

The currency effect is not guaranteed to continue at the same rate. The rupee has depreciated at approximately 3 to 4 percent per annum over long periods driven by the inflation differential between India and the US.

As long as India's inflation exceeds US inflation, some level of structural rupee depreciation is expected. But the rate of depreciation is not constant, and in specific years the rupee can appreciate, reducing the rupee return of a dollar investment below its dollar return.

Period	S&P 500 (USD, total return approx)	USD/INR Change (approx)	S&P 500 in INR (approx)	Nifty 50 in INR (approx)	Nifty 500 in INR (approx)
1 year (2025-26)	+27.67% (CSPX total return)	USD/INR: 83 to 84 (approx +1%)	Approximately +29%	Approximately +5 to 8% (flat to modest positive year in India)	Approximately +4 to 7%
3 years annualised (2022-25)	+20.24% per annum (CSPX)	Rupee depreciated approximately 3.5% p.a.	Approximately +23.7% p.a.	Approximately +13 to 15% p.a.	Approximately +13 to 16% p.a.
5 years annualised (2020-25)	+14.96% per annum (CSPX)	Rupee depreciated approximately 3.5% p.a.	Approximately +18.5% p.a.	Approximately +19 to 21% p.a. (strong bull market 2020-24)	Approximately +20 to 22% p.a.
10 years annualised (2015-25)	Approximately +13 to 15% p.a. (S&P 500 USD)	Rupee depreciated approximately 3.5% p.a.	Approximately +16.5 to 18.5% p.a.	Approximately +13 to 14% p.a.	Approximately 12.93% p.a. (Nifty 500 per PortfoliosLab data)
Since CSPX inception, annualised (2010-25)	+14.10% p.a. (CSPX USD)	Rupee depreciated from ~45 to ~84; approximately 4.1% p.a.	Approximately +18.2% p.a.	Approximately +14 to 15% p.a.	Approximately +13 to 15% p.a.

The table reveals a nuanced picture. Over the 5-year period from 2020 to 2025, Indian equities (Nifty 50 and Nifty 500 in rupee terms) actually matched or modestly outperformed the S&P 500 in rupee terms, driven by India's strong post-COVID recovery and bull market through 2024. Over the 10-year and since-inception periods, the S&P 500 in rupee terms pulls ahead, partly because it includes the exceptional 2019 to 2021 US equity boom and the 2023 to 2024 AI-driven run.

The critical insight from the comparison: the S&P 500 in rupee terms is not always or obviously better than Indian equities. The outcome depends heavily on which period is selected, what happened to US equity valuations during that period, and what the rupee did against the dollar.

The argument for investing in the S&P 500 from India is not primarily that it will definitively outperform Indian equities, but rather that it provides uncorrelated exposure to a different economy and a different set of industries, reducing the concentration risk of an all-India equity portfolio.

The S&P 500 vs Nifty comparison looks different in every period and in every currency. In dollar terms over 10 years, S&P 500 returned approximately 18.43% p.a. vs Nifty 500's 12.93% p.a. The rupee depreciation narrows this gap when both are measured in INR. The case for S&P 500 is diversification, not guaranteed outperformance.

How to Buy CSPX from India: The Step-by-Step Process

Buying CSPX from India requires an international brokerage account funded through the LRS. The process involves the following steps.

• Step 1: Open an international brokerage account. The most commonly used platforms by Indian residents are Interactive Brokers (IBKR) International, Vested Finance (which provides a US brokerage account), and similar platforms. Interactive Brokers provides access to the LSE, allowing purchase of CSPX in USD or GBP. Choose an account that provides LSE access if you specifically want CSPX rather than a US-listed equivalent.

• Step 2: Complete the LRS remittance from your Indian bank. Transfer funds in USD from your Indian bank account to your international brokerage account. This is an outward remittance under the LRS framework. Inform your bank that the purpose is overseas investment in securities. The bank will deduct 20 percent TCS on amounts above Rs 7 lakh per year, which is recovered at ITR filing as a TCS credit.

• Step 3: Place the order on the LSE. Search for CSPX on the LSE (or ticker CSPX LN in most platforms). The accumulating share class (ISIN IE00B5BMR087) is the most commonly traded and most tax-efficient for Indian investors, because it reinvests dividends within the fund rather than distributing them (distributing dividends would be taxable as income in India). Specify the number of units and the order type (market or limit).

• Step 4: Settlement. CSPX settles on T+2 on the LSE. The shares are credited to your brokerage account. There is no separate demat account required; the international brokerage account holds the shares in custody.

• Step 5: Annual ITR disclosure. You must declare the international brokerage account in Schedule FA of your annual ITR. This is mandatory for all foreign financial accounts held by Indian tax residents. The account value, any income (dividends or gains), and the account details must be reported. Failure to report a foreign financial account under the Black Money Act has serious consequences.

Tax Implications for Indian Investors

The tax treatment of CSPX gains for an Indian resident investor is the least favourable aspect of the direct route compared to a domestic Indian equity fund, and it is the same unfavourable treatment that applies to all domestic international fund-of-funds for post-April 2023 purchases.

Capital gains on the sale of CSPX units are treated as foreign equity capital gains under Indian tax law. These are not eligible for the 12.5 percent LTCG rate that applies to Indian listed equity or equity mutual funds. Instead, they are taxed at the investor's applicable income tax slab rate (10, 20, or 30 percent), regardless of the holding period. Holding CSPX for 10 years does not produce long-term capital gains treatment for Indian tax purposes. Every rupee of gain on CSPX, whether from 6 months or 15 years of holding, is income taxed at slab rate.

Dividends, if any, from a distributing class of CSPX (the IUSA class distributes quarterly) are taxed as income from other sources at slab rate. The accumulating class CSPX reinvests dividends within the fund, so there are no periodic dividends to declare until the units are sold, at which point the accumulated reinvested dividends are embedded in the capital gain. The accumulating class is therefore more tax-deferred than the distributing class for Indian investors.

The currency gain (arising from the rupee's depreciation against the dollar) is embedded in the total gain and taxed as part of the capital gain. If you bought CSPX at USD 400 per unit when USD/INR was 70 (costing Rs 28,000 per unit) and sell at USD 800 when USD/INR is 84 (receiving Rs 67,200 per unit), the total gain in rupees is Rs 39,200.

The dollar gain was USD 400, and the currency gain was Rs 39,200 minus the equivalent of USD 400 in today's rupees plus the dollar gain. Both are taxed together as a single slab-rate capital gain.

Tax Aspect	Direct CSPX via LRS	Domestic S&P 500 FoF (e.g. Motilal Oswal)	Domestic Nifty 50 Index Fund
Capital gains tax rate	Slab rate (10%, 20%, or 30%)	Slab rate (same; non-equity fund classification)	12.5% LTCG after 12 months holding (equity fund)
Holding period benefit	None; slab rate regardless of holding period	None; slab rate regardless of holding period	LTCG at 12.5% after 12 months; STCG at 20% before 12 months
Annual disclosure requirement	Schedule FA in ITR (mandatory; Black Money Act); foreign account disclosure	None; domestic fund; no foreign account disclosure needed	None; domestic fund
TCS on investment amount	20% TCS on LRS above Rs 7 lakh; recovered at ITR filing	None; rupee investment in domestic fund	None; domestic fund
Effective annual cost	0.07% expense ratio (CSPX); plus LRS admin; plus TCS timing cost	0.50 to 0.65% expense ratio (domestic wrapper) + 0.07% CSPX embedded = 0.57 to 0.72% total	0.04 to 0.10% (Nifty 50 index fund); direct plan
Tax on Rs 10 lakh gain for 30% bracket investor	Rs 3 lakh (30% slab rate)	Rs 3 lakh (same slab rate)	Rs 1.1 lakh approximately (12.5% LTCG on gain above Rs 1.25 lakh exemption)

The key insight from the tax comparison: the direct LRS route to CSPX is tax-equivalent to the domestic Indian S&P 500 FoF for new purchases, but has a lower expense ratio (0.07 percent vs 0.57 to 0.72 percent total for the domestic wrapper). Both are significantly less tax-efficient than a domestic Nifty 50 index fund for investors in the 30 percent bracket. The direct CSPX route wins on cost but shares the same tax disadvantage versus domestic Indian equity funds.

CSPX vs Domestic Indian S&P 500 FoF: The Cost Advantage Over Time

The cost advantage of CSPX (0.07 percent) over a domestic Indian S&P 500 FoF (approximately 0.57 to 0.72 percent total including the domestic wrapper and the underlying ETF cost) is the primary reason to prefer the direct route. This 0.50 to 0.65 percent annual cost saving compounds meaningfully over long holding periods.

On a Rs 10 lakh initial investment growing at 12 percent per annum for 20 years: at 0.07 percent annual cost, the terminal value is approximately Rs 88.7 lakh. At 0.65 percent annual cost, the terminal value is approximately Rs 80.5 lakh. The cost difference over 20 years is approximately Rs 8.2 lakh, or 82 percent of the original investment. This is not a small number. It is the mathematical case for preferring the direct route when the investment horizon is long.

The trade-offs of the direct route are the operational complexity (LRS process, Schedule FA disclosure, TCS management), the lack of a SIP mechanism (you must manually reinvest periodically rather than setting an automatic monthly investment), and the need to manage an international brokerage account relationship. For investors who are comfortable with these operational requirements and have a meaningful and consistent international equity allocation (Rs 5 lakh or more per year), the direct CSPX route is more cost-efficient over long periods.

For investors with smaller amounts, less frequent investments, or limited comfort with international brokerage account management, the domestic FoF route's higher cost buys operational simplicity that may be worth the price. The cost-convenience trade-off is a personal decision, and neither choice is objectively wrong for all investors.

Why Bother at All? The Diversification Case for S&P 500 from India

Given that the S&P 500 through CSPX is taxed at slab rate (the same disadvantage as any overseas investment for a 30 percent bracket Indian investor), and that the Nifty 50 and Nifty 500 have matched S&P 500 returns in rupee terms over the past 5 years, the question of why an Indian investor should bother with CSPX deserves an honest answer.

The case is not return maximisation. It is risk reduction through low correlation. The correlation between the Nifty 500 and the S&P 500 in dollar-equivalent returns is approximately minus 0.01, meaning they are essentially uncorrelated. In periods when Indian markets do poorly (political uncertainty, current account stress, RBI tightening, global risk-off affecting emerging markets), the US market may do well or independently poorly for its own reasons. Holding both reduces the volatility of the combined portfolio even if the expected returns are similar.

A portfolio that is 100 percent Indian equity is concentrated in one country's political risk, one currency, one central bank's policy cycle, and a market that is dominated by financials, consumer companies, IT services, and energy. A portfolio with 20 percent in CSPX and 80 percent in Indian equity has meaningful exposure to US technology, US healthcare, US consumer brands, and US financials that are completely absent from the Indian listed market. This sector and country diversification reduces the risk of a single negative India-specific event devastating the entire portfolio.

The honest long-term truth: neither Indian equity nor US equity will definitively outperform the other over the next 20 years with the confidence required to go all-in on one. Holding both is the rational response to that uncertainty.

Who Should Buy CSPX Directly and Who Should Use the Domestic FoF Route

The direct CSPX route via LRS is most appropriate for investors who are committed to a meaningful and consistent international equity allocation of at least Rs 5 lakh per year; who have the administrative comfort to manage an international brokerage account, the LRS remittance process, TCS recovery at ITR filing, and Schedule FA disclosure; and who have a long investment horizon where the 0.50 to 0.65 percent annual cost saving over the domestic FoF route compounds into a material return advantage.

The domestic Indian FoF route (Motilal Oswal S&P 500, ICICI Pru Nasdaq 100, and similar) is more appropriate for investors who prefer a single domestic rupee-denominated SIP account; who invest smaller amounts per year (below Rs 3 to 5 lakh); who are not comfortable managing an international brokerage account and ITR Schedule FA disclosure; and who value the convenience of a domestic platform for all investments regardless of the cost difference.

The domestic FoF also does not require TCS management, making it simpler for investors who find the 20 percent TCS on LRS remittances above Rs 7 lakh administratively burdensome.

Disclaimer: This article is for educational purposes only and does not constitute financial, legal, tax, or investment advice. CSPX return data is sourced from BlackRock's published fact sheet (November 2025) and public market data. Return comparisons between S&P 500 and Indian indices use approximate data from publicly available sources and should not be treated as precise historical figures. Tax treatment of CSPX gains for Indian residents is based on the Income Tax Act as understood in June 2026 and subject to change. LRS rules, TCS provisions, and Schedule FA requirements are subject to regulatory change. Please consult a SEBI-registered financial adviser and a chartered accountant with international investment experience before investing in CSPX or any overseas security. We are merely reviewing this product and shwoing ways to invest in it. We are not affiliated with the product or the owners of the product. We do not recieve any form of commission from any parties.